Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-19, Stock:ABBV, The news for the past five days is as follows:
2021-03-12: NEWS1: Top Stock Reports for Netflix, Toyota & AbbVie.
2021-03-15: NEWS1: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS2: Exclusive: AbbVie in talks to sell $5 billion women's drugs portfolio - sources.NEWS3: The Zacks Analyst Blog Highlights: Netflix, Toyota, AbbVie, Merck and Sinopec.
2021-03-16: NEWS1: A Look Into AbbVie's Price Over Earnings.NEWS2: AbbVie Seeks To Offload Allergan's Women's Health Unit: Reuters.NEWS3: 3 Stocks That'll Turn Your $1,400 Stimulus Check Into a Money Machine.NEWS4: AbbVie Reportedly Plans to Sell $5 Billion Women's Drugs Unit.NEWS5: Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD.
2021-03-17: NEWS1: Did Pfizer Just Trip Up AbbVie's Chances For A New Arthritis Drug?.NEWS2: FDA Pushback on AbbVie Drug Raises More Alarms for Biotechnology.NEWS3: REFILE-UPDATE 1-U.S. FDA extends review period for expanded use of Abbvie's arthritis drug.NEWS4: U.S. FDA extends review period for expanded use of Abbvie's arthritis drug.NEWS5: AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Adults with Active Psoriatic Arthritis.NEWS6: The FTC Is Taking a More Aggressive Approach Toward Pharmaceutical M&A. What It Means for the Industry..NEWS7: AbbVie Slumps After FDA Extends Psoriatic Arthritis Drug Review.NEWS8: 4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package.
2021-03-18: NEWS1: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV.NEWS2: ETF looks to help private sector address women’s issues.NEWS3: AbbVie (ABBV) Down as FDA Extends Review of Rinvoq sNDA.NEWS4: Pharma Stock Roundup: J&J, AZN COVID-19 Update, FDA Delays Decision on ABBV's sNDA.

Answer: Decrease